about
Multi-omics and Alzheimer's disease: a slower but surer path to an efficacious therapy?Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative DementiasDifferential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Applying fluid biomarkers to Alzheimer's disease.
@en
Applying fluid biomarkers to Alzheimer's disease.
@nl
type
label
Applying fluid biomarkers to Alzheimer's disease.
@en
Applying fluid biomarkers to Alzheimer's disease.
@nl
prefLabel
Applying fluid biomarkers to Alzheimer's disease.
@en
Applying fluid biomarkers to Alzheimer's disease.
@nl
P2860
P1476
Applying fluid biomarkers to Alzheimer's disease.
@en
P2860
P304
P356
10.1152/AJPCELL.00007.2017
P577
2017-04-19T00:00:00Z